Chronic inflamation, closely associated with frailty and age-related diseases, is a hallmark of aging. Mayo Clinic researchers have discovered that inhibiting key enzyme pathways reduces inflammation in human cells in culture dishes and decreases inflammation and frailty in aged mice.
The results appear today in Proceedings of the National Academy of Sciences of the United States of America. While further studies are needed, researchers are hopeful that these findings will be a step toward treatments for frailty and other age-related chronic conditions.
In the study, researchers found that Janus kinase (JAK) inhibitors, drugs that work to block activity of JAK enzymes, decreased the factors released by human senescent cells in culture dishes. Senescent cells are cells that contribute to frailty and diseases associated with aging. Also, these same JAK inhibitors reduced inflammatory mediators in mice. Researchers examined aged mice, equivalent to 90-year-old people, before and after JAK inhibitors. Over the course of two months, the researchers found substantial improvement in the physical function of the aged mice, including grip strength, endurance and physical activity.
Read more: Researchers reduce inflammation in human cells, A major cause of frailty
The Latest on: Chronic inflammation
[google_news title=”” keyword=”chronic inflammation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Chronic inflammation
- 6 'Highly Inflammatory' Groceries Doctors Say You Should Leave Out Of Your Cart—And Healthy Swaps To Try Instead: Avoid Processed Meats & Moreon April 26, 2024 at 5:00 am
Embarking on a trip to the grocery store is more than just filling a cart; it’s an opportunity to nourish your body and support your well-being. However, amidst the plethora of options, it’s essential ...
- Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fighton April 25, 2024 at 11:18 pm
Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation ...
- TikTok Taught Me How to Navigate Chronic Illness — What Happens If It Gets Banned?on April 25, 2024 at 7:15 pm
Chandler Plante is an assistant editor for POPSUGAR Health & Fitness. Previously, she worked as an editorial assistant for People magazine and contributed to Ladygunn, Millie, and Bustle Digital Group ...
- Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunctionon April 25, 2024 at 6:27 am
A South Korean team has spearheaded a research endeavor that successfully uncovered the mechanisms governing inflammation and metabolic dysfunction in tissues associated with obesity. Their findings ...
- Ted Danson Has Lived With Psoriasis for 50 Years—Here Are the Dermatologist-Approved Ways He Combats Chronic Inflammationon April 24, 2024 at 12:45 pm
Actor Ted Danson and dermatologist Jennifer Soung shared the importance of seeking care for conditions like plaque psoriasis, plus some of the best ways to complement treatment.
- Neuroscientists report a distinct role of touch receptors in treating chronic painon April 23, 2024 at 7:01 am
People often experience the phenomenon of injuring a hand and feeling relief from vigorously shaking it. The mechanism behind this effect is fairly well explained by the "gate control theory" of ...
- HealthWatch: Inflammation + Poverty = A Recipe for Dying Youngon April 22, 2024 at 8:30 am
Each year at the doctor’s office, many adults get their blood pressure taken and cholesterol levels checked. Doctors make sure you’re not anemic, have enough ...
- Medical Moment: How poverty impacts inflammationon April 19, 2024 at 6:38 pm
There’s one test that some believe your doctor may be missing, and that one could be life-saving for millions of people.
- Health Beat: Inflammation and povertyon April 16, 2024 at 1:00 pm
Diabetes, cardiovascular disease, arthritis, allergies and COPD are all life-threatening conditions as well as chronic inflammation diseases.
- OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effectiveon April 16, 2024 at 9:00 am
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective NANTES, France, April 16, 2024 – SA (ISIN: FR0012127173; Mnemo ...
via Bing News